Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | USFD | CMS |
|---|---|---|
| Price | $92.31 | $63.54 |
| Change today | ▲ 0.10% | ▲ 0.73% |
| Market cap | $19.97B | $19.92B |
| Return, 3 months | -9.4% | -15.6% |
| Return, year to date | +22.6% | -6.6% |
| Return, 1 year | +22.6% | -9.0% |
| P/E (TTM) | 28.4 | 19.1 |
| P/B | 4.7 | 2.1 |
| P/E percentile vs own 5y | 26th | 27th |
| Dividend yield | – | 3.50% |
| Revenue growth (YoY, latest qtr) | +4.5% | -0.5% |
| Net profit growth (YoY) | +22.8% | -50.3% |
| Gross margin | 17.6% | 40.3% |
| Operating margin | 3.2% | 18.9% |
| Net margin | 1.8% | 11.5% |
| Return on equity | 16.4% | 11.5% |
| Analyst target vs. price | +25.3% | +24.7% |
| Analyst buy share | 78% | 54% |
| RSI (14) | 29 | 27 |
| 30-day volatility | 22.5% | 12.7% |
| Max drawdown, 1 year | -21.1% | -20.1% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
